MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Dystonia: Treatment"

  • 2018 International Congress

    Education in hyperkinetic movement disorders in Cameroonian health providers

    M.H.G. Monje, M.M. Kurtis, M. Molina, C. Delgado-Suárez, P. Gómez-Iglesias, I. García-Morales, D. García-Azorín (Móstoles, Madrid, Spain)

    Objective: To evaluate the educational gaps in hyperkinetic movement disorders among a widely-varied sample of Cameroonian health providers and improve understanding through a practical training…
  • 2018 International Congress

    Phenomenology and management of subthalamic stimulation-induced dyskinesia in a video case series of patients with isolated dystonia

    K. Dodenhoff, I. Bledsoe, M. San Luciano, M. Volz, L. Markun, P. Starr, J. Ostrem (San Francisco, CA, USA)

    Objective: To document with videotaped observations, 3 patients with isolated dystonia who experienced stimulation-induced dyskinesia (SID) following subthalamic nucleus (STN) deep brain stimulation (DBS). Background:…
  • 2018 International Congress

    Effect of lidocaine injection into the external oblique muscle on camptocormia and the lateral slant posture in patient with Parkinson’s disease

    Y. Higashi, M. Tabata, T. Tabuchi, Y. Hattori (Himeji, Japan)

    Objective: Camptocormia (CC) is one of the abnormal posture of Parkinson's disease (PD) patients, described as a severe forward flexion of the trunk. In this…
  • 2018 International Congress

    Response to botulinum toxin in adult onset lower limb dystonia

    D. Ehrlich, K. Alter, B. Karp (Bethesda, MD, USA)

    Objective: To describe the response to treatment with botulinum toxin in a cohort with adult onset lower limb dystonia. Background: Adult onset, lower limb dystonia…
  • 2018 International Congress

    Botulinum toxin injection for Pisa syndrome in Parkinson’s disease

    CA. Artusi, M. Zibetti, P. Barbero, M. Busso, S. Bortolani, S. De Mercanti, P. Arnoffi, M. Fabbri, A. Merola, L. Lopiano (Torino, Italy)

    Objective: We sought to assess the clinical efficacy of Botulinum toxin (BoNT) injection for Pisa syndrome (PS) using a combined Magnetic Resonance Imaging (MRI)-, Ultrasonography…
  • 2018 International Congress

    Paroxysmal multifocal dystonia with hemiplegic migraine possibly related to novel CACNA1A mutation

    A. Hannoun, K. Smith (Worcester, MA, USA)

    Objective: To report a case of a unique clinical presentation of hemiplegic migraine associated with paroxysmal multifocal dystonia possibly related to a novel CACNA1A mutation.…
  • 2018 International Congress

    Movement Disorders as Postinfectious Neurologic Syndromes

    H. Mori (Kurashiki, Okayama, Japan)

    Objective: We shows the three patients which some neurologists diagnosed psychological disorders at first. Their movement disorders are due to postinfectious neurologic syndromes (Epstein-Barr virus…
  • 2018 International Congress

    Zolpidem effect in task specific dystonia – clinical and neurophysiological study

    K. Vogelnik, M. Grmek, R. Perellon Alfonso, P. Tomše, M. Trošt, M. Kojović (Ljubljana, Slovenia)

    Objective: We conducted a double blind, placebo-controlled crossover study to examine clinical and neurophysiological effect of zolpidem in patients with task specific dystonia. Background: Task…
  • 2017 International Congress

    Protocol for upper-limb kinematic analysis in paediatric movement disorders and relative normality data

    L. Garavaglia, E. Pagliano, A. Lo Mauro, G. Baranello, A. Aliverti, S. Pittaccio (Lecco, Italy)

    Objective: The study proposes a specialised protocol to collect and analyse kinematic data from paediatric patients affected by Movement Disorders (MD). The aim is to…
  • 2017 International Congress

    Clinical Relevance of Treatment With OnabotulinumtoxinA in Patients With Cervical Dystonia: Results From the CD Probe Study

    K. Dashtipour, Z. Mari, J. Jankovic, C. Adler, M. Schwartz, M. Brin (Loma Linda, CA, USA)

    Objective: To explore minimal clinically important change perceived by patients as beneficial by the Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS) using data from the…
  • « Previous Page
  • 1
  • …
  • 28
  • 29
  • 30
  • 31
  • 32
  • …
  • 39
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • #24970 (not found)
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • To be or not to bupropion: a drug-induced parkinsonism?
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley